Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A commentary on high-cost drugs.

R F de Leon

    Current Concepts in Hospital Pharmacy Management
    |March 5, 1990
    PubMed
    Summary

    Ultra-expensive drugs require careful management to control costs. Pharmacy departments must implement inventory control, protocol management, and drug-use evaluation to ensure financial viability.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacy database for tracking drug costs and utilization.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
    Same author

    Selecting a pharmacy computer system for the future.

    Pharmacy practice management quarterly·1995
    Same author

    Home parenteral nutrition: a hospital-based program with commercial logistic support.

    JPEN. Journal of parenteral and enteral nutrition·1984
    Same author

    Patient-care unit system for measuring clinical and distributive pharmacy workload.

    American journal of hospital pharmacy·1980
    Same author

    Quality assurance in the provision of hospital care. Medication process: who's responsible?

    Hospitals·1974
    Same author

    The Frame System: a second generation unit-dose distribution system.

    Hospital progress·1972

    Area of Science:

    • Health Economics
    • Pharmaceutical Management
    • Pharmacoeconomics

    Background:

    • The pharmaceutical market is introducing novel, ultra-expensive drugs.
    • These high-cost medications present significant financial challenges for healthcare systems.
    • Existing cost-analysis frameworks may be insufficient for these new agents.

    Purpose of the Study:

    • To outline strategies for managing the financial impact of ultra-expensive drugs.
    • To emphasize the need for comprehensive cost-benefit analyses beyond acquisition price.
    • To guide pharmacy and therapeutics committees in drug approval processes.

    Main Methods:

    • Implementing robust inventory control procedures.
    • Establishing strict protocol management for drug use.
    • Conducting thorough drug-use evaluations.
    • Educating healthcare professionals, administrators, and financial managers.

    Main Results:

    • Identification of hidden costs beyond drug acquisition, including management and education.
    • Recognition of cost offsets such as reduced hospital stays and lifetime cost analyses.
    • The necessity of a paradigm shift in cost-effectiveness evaluation.

    Conclusions:

    • Effective management of ultra-expensive drugs necessitates proactive financial stewardship.
    • A holistic approach considering both direct and indirect costs and offsets is crucial.
    • Healthcare organizations must adapt their financial analysis methods to accommodate these advanced therapies.

    Related Experiment Videos